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In this study, Forty-one out of ﬁfty-seven Tunisian children with B-lineage acute lymphoblastic leukemia (B-ALL), and without
cytogenetically detectable recurrent abnormalities at the time of the diagnosis, were evaluated by ﬂuorescence in situ hybridization
(FISH) for the t(12;21). This translocation leads ETV6-RUNX1 (previously TEL-AML1) fusion gene. 16 patients (28%) had ETV6-
RUNX1 rearrangement. In addition to this rearrangement, two cases showed a loss of the normal ETV6 allele, and three others
showed an extra signal of the RUNX1 gene. Seven patients without ETV6-RUNX1 rearrangement showed extra signals of the
RUNX1 gene. One out of the 7 patients was also associated with a t(3;12) identiﬁed by FISH. This is the ﬁrst Tunisian study in
which we report the incidence of t(12;21) among childhood B-lineage ALL and in which we have found multiple copies of RUNX1.
Finally, our ﬁndings conﬁrm that additional or secondary genetic changes are commonly encountered in pediatric B-lineage ALL
with ETV6-RUNX1 gene fusion which is envisaged to play a pivotal role in disease progression.
Copyright © 2009 Abir Gmid` ene et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The t(12;21)(p13;q22) translocation is the most common
genetic alteration in childhood B-cell acute lymphoblastic
leukemia occurring in approximately 25% of cases and is
associated with a favorable outcome [1, 2].
The molecular consequence of this translocation is the
fusion of two known genes: ETV6 mapped to 12p13 and
RUNX1 located at 21q22 [1, 3]. It results in the formation
of a hybrid protein involving the helix-loop-helix domain
of ETV6 and the entire RUNX1 gene that appears to
interfere with transactivation by the normal RUNX1 in a
transdominant manner [3, 4].
Becauseitisacryptictranslocationwhichusuallyescapes
diagnosis on conventional cytogenetic (CC) study due to the
similarity of the changed bands, molecular cytogenetic tools
such as ﬂuorescence in situ hybridization (FISH) are needed
to determine the incidence of the ETV6-RUNX1 fusion in
the Tunisian B-lineage ALL pediatric cases that had normal
karyotypes or random chromosome aberrations at diagnosis
and to compare our ﬁndings to those previously described in
literature.
2. Methods
2.1. Patients. Among 57 childhood B-lineage ALL cases ana-
lyzed by conventional karyotype, 41 were selected for FISH
analysis according the following criteria: age (0–16); absence
of cytogenetically detectable recurrent abnormalities, that
is, high hyperdiploid karyotypes (51–65 chromosomes),
t(4;11), t(1;19), and t(9;22). Theses patients are referred
to our laboratory for cytogenetic analyses from diﬀerent
hematological services in Tunisia.
2.2. Conventional Cytogenetics. Chromosomal preparations
with RHG-banding were performed according to a previ-
ously described protocol [5].2 Advances in Hematology
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Figure 1: (a) an interphase cell with no translocation, (b) An interphase cell with two ETV6-RUNX1 fusion signals (yellow), (c) a metaphase
cell with an ETV6-RUNX1 fusion signal and deletion of the second ETV6 allele (missing a red signal from the cell), (d) an interphase cell
with ETV6-RUNX1 fusion signal and an extra copy of the RUNX1 gene, (e) two interphase cells with extra copies of the RUNX1 gene and
without ETV6-RUNX1 fusion, (f) t(3;12) with a marker chromosome that harbored an extra copy of the RUNX1 gene.
Chromosomes were identiﬁed and arranged according
to the international system for human cytogenetic nomen-
clature (ISCN 2005) [6], and the karyotype proﬁle was
determined by the analysis of at least 20 metaphases.
2.3. Fluorescence In Situ Hybridization (FISH). The presence
of the ETV6-RUNX1 fusion gene was assessed using two
YAC clones (the YAC936E2 and the YAC821S11) selected
from their location in the 12p13 (ETV6) and the 21q22
(RUNX1) regions, respectively, in the “Centre d’Etude du
Polymorphisme Humain Database” (http://www.cephb.fr/).
The ETV6 and the RUNX1 probes were labeled with
tetramethylrhodamine-6-dUTP and ﬂuorescein 12-dUTP
(Abbott-Vysis, Downers Grove, IL, USA), respectively, using
nicktranslationkit(Abbott-Vysis,DownersGrove,IL,USA).
For FISH technique, slides were denatured in 70%
formamide at 75
◦C for 1 minute and 30 seconds then
dehydrated with cold (−20
◦C) 70%, 85%, and 100% ethanol
for 1 minute and 30 seconds each.
After drying, the ETV6-RUNX1 dual-color FISH probe,
denatured as preliminary at 75
◦C for 5–10 minutes, was
applied into a slide, covered with a 24 × 24mm coverslip
and sealed with a rubber cement. Slides were then placed
in a humid light-proof container at 37
◦C for overnight
hybridization.
After hybridization, the coverslip was removed and slides
were washed in 0.4 standard saline citrate (SSC) for 5
minutes at 75
◦C, followed by a second wash in 2XSSC-0.1%
NP40 for 2 minutes.
After drying, the slides were counterstained with 4’,6-
diamidino-2-phenylindole and examined with a ﬂuorescent
microscope equipped with appropriate ﬁlters and CytoVi-
sion FISH system image capture software (Zeiss Axioskop
2 plus) and at least 50 metaphase cells, and 100 interphase
nuclei were analyzed for ETV6-RUNX1 translocation.
In a normal case, the hybridization with the ETV6 (red)
and the RUNX1 (green) probes showed two red and two
green signal patterns (Figure 1(a)). However, in a case with
the t(12;21), the hybridization with these probes showed one
or two fusion signals (red/green or yellow), one red and one
green signal patterns corresponding to the normal copies of
the ETV6 and the RUNX1 genes, respectively, (Figure 1).
3. Results
Among 57 children with B-lineage ALL, 16 cases were not
screened for this study (4 cases with t(9;22)(q34;q22) from
which one was also associated to a hyperdiploid karyotype
with 53 chromosomes, 1 case with t(1;19)(q23;p13), 1 case
with t(8;14)(q24;q32), 2 cases with t(4;11)(q21;q23), 2 cases
with del(9)(p12p23), 1 case with del(11)(q23), 3 cases with
del(6q), and 2 cases with high hyperdiploidy (53 and 56
chromosomes). Both are associated to an add(14)(q32).
The selected 41 cases included 25 males and 16 females
with age ranging from 1.2 to 15 years (mean 7.4 years).
Twenty-three out of the 41 patients (56%) had abnormal
FISH ﬁndings (Table 1).Advances in Hematology 3
Table 1: Summary of patients with abnormal FISH ﬁndings.
Patients Age/sex (years) Karyotype (number of cells) FISH signals (No.) %o fc e l l s
ETV6 RUNX1 ETV6-RUNX1 fusion
1 13/M 46, XY[20] 0 1 2 15
2 2/M 46, XY[16] 0 1 1 16
3 5/M 46, XY, del(20)(p12)[8]/46, XY[10] 1 1 2 17
4 6/M 46, XY[19] 1 2 1 25
5 3/F 46, X, −X, add(3)(q27), + mar[5]/46, XX[15] 3 3 0 18
6 15/F 48, XX, t(2;11)(p12;q23), +20, +21[18] 2 3 0 24
7 13/M 46, XY, −16, +mar[9]/46, XX[6] 2 3/4 0 14
8 2/F 46, XX[20] 2 4 0 19
9 7/M 46, XY[20] 1 1 1 14
10 4/F 46, XX[21] 1 1 1 23
11 14/M 46, XY[20] 1 1 1 32
12 4/F 46, XX[21] 1 1 1 17
13 4/F 46, XX[17] 1 1 1 15
14 5/M 46, XY[21] 1 2 1 44
15 3.5/F 46, XX[19] 1 1 1 22
16 14/M 46, XX, −1, dic(1;16)(p31;p13)X2,−21,+2mar[16] 2 3 0 14
17 13/M 47, XXY, del(12)(p12−p13)[8]/47, XXY[12] 2 3 0 16
18 7/F 47, XX, +5[9]/46, XX[3] 1 1 1 17
19 8/M 46, XY[18] 1 1 1 27
20 4/F No metaphases 1 1 1 41
21a 4/F 46, XX[17] 1 1 1 18
22 3/M 46, XY[19] 1 1 1 22
23 1.2/M 46, XY[19] 2 3 0 14
aThis case harbored two distinct clones: one with only the ETV6/RUNX1 rearrangement and the second (9% of cells) with an extra signal of RUNX1 gene.
No: number.
FISH analysis disclosed 16 positive cases for ETV6-
RUNX1 fusion gene among 57 pediatric B-lineage ALL cases
(28%). 13 presented a normal karyotype (cases 1, 2, 4, 9, 10,
11,12,13,14,15,19,21,22)and2hadrandomchromosomal
aberrations(cases3and18),andintheremainingcase,itwas
not possible to obtain adequate chromosomal preparations
(case 20). Two of those sixteen patients (cases 1 and 3) had
two fusion signals (Figure 1(b)).
Additional chromosomal aberrations accompanying the
t(12;21) were found in ﬁve patients (31.2%). Deletion of
nontranslocated ETV6 allele was detected in two patients
(cases 1 and 2) (Figure 1(c)), and three patients without
+21 showed extra signal of RUNX1 (cases 4, 14, and 21)
(Figure 1(d)). Those include a case in which the clone
with the extra signal of RUNX1 was distinct from the one
harboring ETV6-RUNX1 fusion gene (case 21, Table 1).
Extra copies of RUNX1 gene were also detected in 7 cases
without t(12;21); three of which (cases 8, 17, and 23) do not
have+21onthekaryotype.Inthefourcasesremaining(cases
5, 6, 7, and 16) the number of RUNX1 signals detected by
FISH was in agreement with the number of chromosome 21
orthepresenceofmarkerchromosomes(Figure1(e)).Ofthe
cases, one (case 5) was associated with t(3;12) detected by
metaphase FISH (Figure 1(f)).
4. Discussion
Inthepresentstudy,weusedFISHforthedetectionofETV6-
RUNX1 fusion gene in 41 children with B-lineage ALL that
had normal karyotypes or random chromosome aberrations
at diagnosis. To our knowledge, this is the ﬁrst report of
the frequency of the t(12;21) from Tunisia and the second
from an Arab country after the Egyptian study published by
Mikhail et al. in 2002 [7].
ETV6-RUNX1 rearrangement was present in 16 of the 57
selected subgroup of Tunisian patients with B-lineage ALL
(28%). Of them, 13 (13/16, 81%) had a normal karyotype
at diagnosis, a percentage higher than previously reported by
Veiga et al. in Brazil (6/12, 50%) [8] and by Douet-Guilbert
et al. [9] in France (2/10, 20%).
We conﬁrm so the eﬃciency of FISH technique in
the detection of such cryptic chromosomal rearrangement,
usually missed by CC [10, 11].
In Egypt, UK, India, Korea, and Malaysia, ETV6-RUNX1
rearrangement was found with a lower frequency than we
have found, ranging from 0 to 22% [7, 12–14].
However, in B-lineage ALL patients of Germany [11],
Italy [11], and France [15], the frequency of this translo-
cation is reported to be about 25%. A frequency of 31% is4 Advances in Hematology
found among American patients [16], and we recently report
in Israel [17] and in Brazil [8] an incidence of 40%.
This diﬀerence could be explained by the fact that due
to the expected peak incidence at 3–5 years reported in
the majority of the published series, our cases could have
been biased for old age (mean age 7.4 years), which then
corresponds to lower t(12;21) incidence.
The ETV6-RUNX1 fusion gene on the der(21) was
detected in all patients with t(12;21), whereas the reciprocal
ETV6-RUNX1 fusion gene on the der(12) was observed in
only two cases.
While this t(12;21) may initiate the leukemic process,
critical secondary genetic events found in association with
ETV6-RUNX1 fusion gene are currently believed to be
pivotal for leukemogenesis and are previously reported in
literature [4, 18–20].
In our study, additional chromosomal aberrations were
found in ﬁve patients among ETV6-RUNX1 fusion positive
cases (31.2%).
Twopatients(12.5%)showeddeletionofthenontranslo-
cated ETV6 allele. This deletion has been reported in several
studiesbutitsincidenceishighlyvariable,rangingfrom8.6%
to 87.5% [2, 7, 9, 21–23].
This low detection of del(12) in our study could be
explained by the fact that the ETV6 FISH probe covered
almost the entire of the ETV6 gene so that submicroscopic
deletion could be missed.
According to the Knudson’ hypothesis [9], ETV6 could
act as a tumor suppressor gene, with t(12;21) disrupting one
copy of ETV6 and the deletion being the second inactivating
event [17, 21].
In the three other patients, we have found extra copies of
the RUNX1 gene in which the clone with the extra signal of
RUNX1 was distinct from the one harboring ETV6-RUNX1
fusion gene.
Interestingly, extra copies of RUNX1 gene were also
observed in 7 patients without ETV6-RUNX1 fusion. Of
them, three do not have +21 on their karyotype which is
likely consistent with extra 21 perhaps in a small clone not
observed cytogenetically or derive from non dividing clonal
hyperdiploid cell, while normal metaphases derived from
normal dividing cells.
In the four remaining cases, the number of RUNX1
signals was in keeping with results on CC including a case
(case 5) in which we have identiﬁed a t(3;12) by FISH. This
translocation has previously been reported in a case with B-
lineageALLbutinassociationwitht(12;21)byYehuda-Gafni
et al. [17]a n dK o b a y a s h ie ta l .[ 19].
Extracopies of the RUNX1 gene were found in 6 patients
(having or not ETV6-RUNX1 fusion gene and without +21
in the karyotype) among 57 patients with B-lineage ALL
(10.5%). This incidence was higher than that previously
reported by Dal Cin et al. [24], Niini et al. [25]a n dm o r e
recently by Busson Le-Coniat et al. [26] who reported only 2
or 3 cases.
Although the real signiﬁcance of these ﬁndings has not
been clariﬁed yet, the hypothesis of the gene-dosage eﬀect
involving RUNX1 seems to be very probable [27, 28].
In summary, our ﬁndings demonstrate that ETV6-
RUNX1 fusion gene is a common genetic abnormality
detected by FISH in 28% of Tunisian children with B-
lineage ALL, and we conﬁrm that secondary genetic events
are commonly encountered in these patients. Interestingly,
extra copies of RUNX1 are frequently found in our series
than those previously reported in other populations and so
warrant further investigation to elucidate the mechanisms
underlying the role of the RUNX1 in leukemogenesis.
Moreover, due to the unknown prognostic signiﬁcance of
this abnormality, further studies should be conducted in
consecutive children with ALL to correlate RUNX1 overex-
pression with the patients’ followup.
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